Moleculin Biotech, Inc.MBRXEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Moleculin Biotech, Inc. is a clinical-stage biotechnology company focused on developing innovative oncology therapies for difficult-to-treat cancers. Its core pipeline includes candidates targeting brain tumors, pancreatic cancer and other rare malignancies, with primary operations in the United States addressing high unmet patient needs.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 301.0K | flat | 2024-11-14 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.